B. Riley analyst Nick Giles raised the firm’s price target on United States Antimony (UAMY) to $13 from $11 and keeps a Buy rating on the shares. While the delay of the Thompson Falls expansion is a near-term “blemish,” the price target is being raised due to the increased scope of feedstock procurement and the continued prioritization of domestic antimony supply, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UAMY:
- US Antimony: Integrated Growth Strategy and Government Contract Support 45% Upside Potential
- United States Antimony price target raised to $11.50 at H.C. Wainwright
- Closing Bell Movers: FedEx jumps 9% on earnings beat
- United States Antimony reports FY25 EPS (4c) vs. (2c) last year
- US Antimony options imply 10.0% move in share price post-earnings